GYNECOLOGIC CANCERS

Latest News

Olaparib Rechallenge Offers PFS Improvements in Ovarian Cancer
Olaparib Rechallenge Offers PFS Improvements in Ovarian Cancer

February 22nd 2024

Findings from the phase 3b OReO study showed that patients with ovarian cancer who previously received a PARP inhibitor benefitted from a rechallenge with olaparib.

Advancements in Targeted Therapies Revolutionize Ovarian Cancer Treatment
Advancements in Targeted Therapies Revolutionize Ovarian Cancer Treatment

February 15th 2024

Underrepresentation Threatens Equity in Gynecologic Cancer Trials
Underrepresentation Threatens Equity in Gynecologic Cancer Trials

February 2nd 2024

Pembro/Lenvatinib Effective in Endometrial Cancer, Regardless of Mutations
Pembro/Lenvatinib Effective in Endometrial Cancer, Regardless of Mutations

January 26th 2024

FDA Approves Pembrolizumab Plus Chemoradiotherapy in High-Risk Cervical Cancer
FDA Approves Pembrolizumab Plus Chemoradiotherapy in High-Risk Cervical Cancer

January 12th 2024

More News